slides · global inventory
53 Jobs To Be Done
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 1,583
Current window 1,201-1,230
Pages 53
Rows per page 30
Loop
1,201-1,230 of 1,583
20
The slide uses a three-column layout to explain the scientific basis and benefits of the drug.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
21
Includes IC50 value and IFN-y fold increase data from patient samples.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
22
The slide uses a three-column layout to highlight the core benefits of the product.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
98
The slide uses a pie chart to segment the patient population and an MRI scan to illustrate the clinical problem.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
99
The slide uses a combination of quantitative scatter plot data and qualitative imaging to demonstrate drug efficacy.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
100
The slide uses a numbered process flow to explain the mechanism of action of a drug candidate.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
101
The slide uses a split-screen layout to compare two different preclinical efficacy studies.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
102
Slide 102 from a presentation deck.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
103
The diagram uses a layered arrow approach to show cumulative advantages.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
104
The slide uses a process flow diagram to illustrate the clinical trial stages for Cohort A (Phase 2) and Cohort B (Phase 3).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
105
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
106
The slide uses a medical image of polyps to illustrate the condition.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
107
Includes a medical illustration of colonoscopy and a quote from a medical professional.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
108
The chart shows a 'rescue' effect where the drug moves the disease state (red) closer to the healthy state (green).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
109
The slide uses a before-after framework to illustrate the mechanism of action (MoA) of a drug candidate.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
110
The slide uses two distinct chart types (bar chart with error bars and dot plot with mean/SEM bars) to demonstrate efficacy across two metrics.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
111
Clinical: FAP context. Slide 111.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
112
The slide outlines a two-part clinical trial design (Part 1 and Part 2) with specific enrollment criteria and outcome measures.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
113
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
114
Includes a testimonial/quote from a KOL regarding the lack of therapeutic relevance in HCC.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
115
The slide uses a table to quantify the addressable market and a callout box to link preclinical data to the study design.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
116
The slide uses a heatmap to demonstrate biological similarity between drug dosage effects and specific gene regulation.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
117
The slide compares efficacy in mutant vs wildtype models using bar charts for tumor growth inhibition and Kaplan-Meier curves for progression-free survival.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
118
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
119
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
120
The slide uses a three-step process diagram to illustrate the biological mechanism of C. diff infection.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
24
Includes a process diagram for the Signet payment flow.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · ActionLoop · Jobs To Be Done1 hit
25
The slide highlights organic growth and geographic/sector diversification.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · ActionLoop · Jobs To Be Done1 hit
26
Includes a specific callout for taxi medallion losses between 2016-2018.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · ActionLoop · Jobs To Be Done1 hit
27
The slide uses two pie charts to illustrate the change in portfolio mix over a four-year period, highlighting the growth in total loan volume from $36.4B to $74.3B.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · ActionLoop · Jobs To Be Done1 hit